Skip to content

Clinical trials

Phase 3 Diabetic Neuropathies trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Neuropathies Phase: Phase 3 Clear all

63 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20024
20033
20044
20057
20065
20073
20086
20107
20115
20132
20161
20171
20191
20202
20221
20232
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46
Unknown status9
Terminated6
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company8
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.6
UCB Pharma5
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.4
Helixmith Co., Ltd.3
Wyeth is now a wholly owned subsidiary of Pfizer3
Apurano Pharmaceuticals GmbH2
MEDA Pharma GmbH & Co. KG2
Pfizer2
Advanced Magnetic Research Institute International1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Neuropathies63
Pain16
Neuralgia11
Diabetes Mellitus10
Peripheral Nervous System Diseases10
Agnosia3
Chronic Pain3
Diabetes Mellitus, Type 13
Diabetes Mellitus, Type 23
Polyneuropathies3

Trials

Showing 1 to 25 of 63. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.